(IXJ) Global Healthcare - Overview
ETF Category: Health | Exchange: NYSE (USA) | Market Cap: 3.668m USD | Total Return: 12% in 12m
Avg Turnover: 10.2M
Warnings
Extended 3d Choppy
Tailwinds
No distinct edge detected
The iShares Global Healthcare ETF (IXJ) tracks the performance of the S&P Global 1200 Healthcare Index, focusing on large-scale companies critical to the international medical economy. The fund maintains a mandate to invest at least 80% of its assets in index components, with the flexibility to use derivatives and cash equivalents for the remaining 20% to manage liquidity and tracking error.
The healthcare sector typically comprises pharmaceutical manufacturers, biotechnology firms, medical device providers, and healthcare service networks. These business models often rely on high research and development (R&D) expenditures and long-term patent protections to maintain competitive advantages and revenue streams.
For a deeper look into how current interest rates and patent expirations might affect these holdings, you may find further insights on ValueRay. This ETF provides diversified exposure to a sector traditionally characterized by defensive growth, as global healthcare demand remains relatively inelastic regardless of broader economic cycles.
- Pharmaceutical drug pricing legislation impacts margins for top holdings
- GLP-1 weight-loss drug demand drives biopharmaceutical segment revenue
- Global aging demographics increase long-term demand for healthcare services
- US dollar strength creates currency headwinds for multinational healthcare constituents
As of June 08, 2026, the stock is trading at USD 95.63 with a total of 181,023 shares traded.
Over the past week, the price has changed by +1.20%,
over one month by +3.95%,
over three months by -1.79% and
over the past year by +11.95%.
Global Healthcare has no consensus analysts rating.